Status:
RECRUITING
Targeted Intervention on Sleep Disorders During Tobacco or Cannabis Cessation Therapy
Lead Sponsor:
Centre Hospitalier St Anne
Conditions:
Sleep Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
During a cessation therapy for tobacco or cannabis, sleep disorders are one of the main risk factors of relapse, and a symptom of substance withdrawing. In this study, we make the hypothesis that iden...
Detailed Description
Smoking is a serious public health issue in France, with one quarter of the population who smokes on a daily base. Tobacco use represents the first avoidable death cause. Cannabis, often use with toba...
Eligibility Criteria
Inclusion
- patients over 18 years old
- presenting at the participating addiction treatment centres for a smoking or cabannis use cessation therapy
- who agree to participate to the study
- affiliated to the French health insurance system
Exclusion
- Patients hospitalised during the cessation therapy
- Patients undergoing sleep disorders treatment
- Patients participating to another study
- Patients with psychotic disorders (according the DSM-5 classification)
- Patients who do not want the additionnal intervention and care if randomised in the intervention group
Key Trial Info
Start Date :
June 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT07202351
Start Date
June 5 2023
End Date
August 31 2026
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GHU Paris Psychiatrie et Neurosciences
Paris, Île-de-France Region, France, 75014